T he burden of stroke is extremely high. Recent estimations indicated that the global prevalence rate was 5 per 1000 person-years, corresponding to 33 million people living after a stroke. In addition, 5.9 million people suffered a stroke-related death in 2010, and stroke resulted in more than 102 million lost disability-adjusted life years (DALYs), corresponding to the sum of premature death and years of healthy life lost attributed to disability. 1 It is interesting to note that when analyses were stratified by sex, consistent results between studies were found and similar trends in men and women were observed.
There is now a large amount of evidence that ischemic stroke incidence is on the rise in young adults, and the reasons for this trend are probably multiple.
First, it cannot be excluded that the identification of stroke cases improved over time for several reasons. Attitudes of patients toward seeking medical attention or of practitioners toward referring their patients with suspected stroke to specialists may have changed. The increasing use of brain magnetic resonance imaging could have led to better stroke diagnosis, especially in patients presenting with minor or rapidly regressive symptoms. However, if the observed change was exclusively related to better capture and diagnosis of stroke, there is no reason to think that the increasing incidence or hospitalization rates of stroke would only be observed in young people.
Second, trends could reflect changes in the burden of classical vascular risk factors in the young. 10 Indeed, a rise in the prevalence of type 2 diabetes mellitus, hypercholesterolemia, and obesity has been observed in high-income countries. 11, 12 In addition, cigarette smoking and alcohol abuse are frequent in young people and have tended to increase over time. [13] [14] [15] [16] Last, emergent vascular risk factors may also have contributed, in part, to the increase in ischemic stroke. For example, the Greater Cincinnati/Northern Kentucky study reported a rise in the use of illicit drugs among young stroke patients between 1993 and 1994 and 2005. 15 Other contributing factors, such as air pollution, or modifications in life style and habits attributed to the evolution of the society, may also play a role in the rising stroke incidence in young adults and need to be explored further. Finally, despite comprehensive evaluations, the cause of ischemic stroke remains undetermined in approximately one third of young patients ( Figure) . This proportion is even greater in very young people: Cryptogenic strokes account for at least half of overall stroke in patients less than 30 years old. 17 Further studies are required to better characterize these patients so as to identify specific features and the underlying pathophysiology of these undetermined strokes. Stroke incidence increases by a factor of 100 between the age of 40 and 80, thus explaining why only 10% of strokes occur in young people. The aging population is therefore the major contributor of the increase in the absolute number of stroke cases in high-income countries, despite decreasing incidence in the elderly. 1 Any change in the incidence of ischemic stroke in young adults would have only a limited impact on the global incidence of stroke and would be masked by the heavy burden of stroke in the elderly. Nonetheless, given its major socioeconomic impact and the fact that consequences in terms of lost DALYS in young stroke victims is of a major importance, there is an urgent need to improve primary vascular prevention of ischemic stroke in young adults, based on improved and earlier information as well as education of the population. In addition, further research is needed to better understand young-onset stroke.
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